Antithrombotic strategy following valve-in-valve transcatheter aortic valve replacement. A German Statutory Health Claims data analysis
In this analysis of German Health Claims data, DOACs seemed to be a safe alternative to VKAs and APT. ASA monotherapy was associated with higher rates of SSE compared to DAPT. Given the high risk of bias of this retrospective analysis and the growing use of valve-in-valve procedures, randomized controlled trials are needed to confirm these findings.
Authors
- Ursula Marschall (ORCID: https://orcid.org/0009-0008-2607-8996)
- Max M. Meertens (ORCID: https://orcid.org/0000-0002-7746-8723)
- Victor Mauri (ORCID: https://orcid.org/0000-0003-2678-3501)
- Christopher Hohmann (ORCID: https://orcid.org/0000-0003-2821-4134)
- Sascha Macherey‐Meyer (ORCID: https://orcid.org/0000-0002-7080-6611)
- Stephan Baldus (ORCID: https://orcid.org/0000-0001-8259-1737)
- Hendrik Wienemann (ORCID: https://orcid.org/0000-0001-5810-2868)
- Elmar Kuhn (ORCID: https://orcid.org/0000-0001-6301-7422)
- Matti Adam (ORCID: https://orcid.org/0000-0002-6990-8135)
- Sebastian Heyne (ORCID: https://orcid.org/0000-0002-1581-9954)
- Samuel Lee (ORCID: https://orcid.org/0000-0001-6768-7079)
Institutions
- University of Cologne (DE)
- BARMER GEK (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1007/s00392-025-02635-2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universitätsklinikum Köln